Silent Atherosclerosis Unveiled: The PESA and PrevCAD Trials, Plus HDL-Cholesterol and Hair Growth Insights
Heart Doc VIP with Dr. Joel Kahn
English - December 05, 2023 08:00 - 25 minutes - 24.6 MB - ★★★★★ - 412 ratingsAlternative Health Health & Fitness Nutrition healthtips healthyeating cardiologist drjoelkahn drkahn empowerradio greenspacecafe health heartdiseasereversal heartdocvip Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
This week, Dr. Kahn touches on mini-topics regarding HDL-cholesterol and the brain, pumpkin seeds and hair growth, lipoprotein(a), and others. He then shifts focus to the main topic: a 6-year update on the PESA trial in Madrid, followed by a look at the upcoming PrevCAD trial targeting young people. Just like at the Kahn Center, the PESA study in Madrid screened 'healthy' individuals aged 40-55 for silent atherosclerosis. It found that, at the 6-year mark, younger participants with high blood pressure and high LDL-cholesterol experienced rapid worsening of their condition. The PrevCAD trial in NYC will randomize young volunteers, aged 20-39 with silent atherosclerosis, to either receive aggressive therapy or undergo watchful waiting. Stay tuned for some insightful discoveries ahead.